The acquisition is the second in central Indiana this year for Versiti, a not-for-profit specializing in blood-health services.
Read More
The Indianapolis-based drugmaker said it will acquire Sigilon Therapeutics Inc., a six-year-old startup that is developing a technology to help type 1 diabetes patients restore insulin production over sustained periods.
Read More
The pollutants, polyfluoroalkyl and perfluoroalkyl substances—commonly known as PFAS—can be found in many industrial and cosmetic products and have been linked to infertility, thyroid disorders and several types of cancer.
Read More
Host Mason King talks with AgriNovus chief Mitch Frazier, who has one of the most expansive and rounded perspectives of agricultural innovation in the state, details how Indiana is becoming a major player in vital issues of food security.
Read More
The Bloomington plant, with about 1,000 employees, is the fifth-largest employer in Monroe County, according to the Greater Bloomington Chamber of Commerce, and is poised for more growth.
The announcement represents the company’s latest move to meet the soaring demand for its medicines for diabetes and weight loss.
The business makes a hand-sanitizing device called Iggy that kills pathogens with ozone-infused water instead of soap or other chemicals.
The federal designation marks Indiana as a hub for biologics manufacturing. Biologics are medicines derived from biological sources and include vaccines, monoclonal antibodies, and immune modulators.
The technology hub designation makes Indiana eligible to compete against 30 other designated hubs in hopes of landing up to $70 million in federal funding to implement its program.
Following a $45 million renovation, RayzeBio plans to use the plant to make Actinium 225, a radioisotope used for targeted therapy for cancer.
Isotopia USA, the newly formed U.S. subsidiary of Isotopia Molecular Imaging, announced Monday that it will hire 50 people to produce a radioactive medical isotope used in pharmaceuticals for targeted cancer treatment.
With the new multimillion-dollar conference that kicks off on Tuesday, Indiana is trying to position itself as a globally known innovation hub. And health care will figure prominently on the agenda.
The company, which is developing electrical-nerve stimulation therapies for children, went public this month at an initial price of $6 a share—lower than the range of $7 to $9 a share it announced in February.
Quantigen employs 46 people at its office at 10300 Kincaid Drive, and it will retain its name following the deal.
In the health care world, Thermo Fisher Scientific operates mostly behind the scenes, supplying labs and hospitals with scientific instruments, chemical ingredients and software services.
Helmer Scientific, which makes temperature-controlled storage equipment for hospitals, labs, blood banks, and pharmacies, was founded in Noblesville in 1977 and has more than 400 employees.
Two companies, Certus Medical LLC and Radiological Care Services LLC, plan to occupy 50,000 square feet in the 100,000-square-foot building.
The Bloomington-based maker of medical devices said the move is part of a new plan to strongly focus on product innovation.
The CEO of orthopedic industry group OrthoWorx says the $30 million appropriation from the state’s new two-year budget has created excitement within Indiana’s orthopedic industry.
The company reported earnings per share of 45 cents, handily beating Wall Street’s estimate of 29 cents. Elanco shares soared by about 9% Tuesday in premarket trading, to $9.36.
Kyle Mohler founded Insignum Agtech with the idea of rearranging bits of corn’s DNA, then inserting them into popular field-corn hybrids.
Inventors and entrepreneurs who don’t have a track record face the biggest challenges, a panel of experts said Friday morning at IBJ’s Life Sciences Power Breakfast.
BiomEdit LLC was set up last year by Greenfield-based Elanco Animal Health and Boston-based Ginkgo Bioworks to make everything from food to therapeutics for animals. It’s already raised $36.5 million in venture capital for its work.
GeniPhys has developed a material known as Collymer, a highly-purified form of collagen that can be used to replace tissue that is lost in wounds and also forms “stable, fibrillar collagen scaffolds” that can help rebuild lost tissue.
